CO5210947A1 - IMMUNOGENIC COMPOSITIONS THAT INCLUDE A STREPTOCCUS PNEUMONIAE POLISACARIDE ANTIGEN - Google Patents

IMMUNOGENIC COMPOSITIONS THAT INCLUDE A STREPTOCCUS PNEUMONIAE POLISACARIDE ANTIGEN

Info

Publication number
CO5210947A1
CO5210947A1 CO00027743A CO00027743A CO5210947A1 CO 5210947 A1 CO5210947 A1 CO 5210947A1 CO 00027743 A CO00027743 A CO 00027743A CO 00027743 A CO00027743 A CO 00027743A CO 5210947 A1 CO5210947 A1 CO 5210947A1
Authority
CO
Colombia
Prior art keywords
polysaccharide
polysaccharides
antigen
conjugated
protein
Prior art date
Application number
CO00027743A
Other languages
Spanish (es)
Inventor
Carine Capiau
Marguerite Deschamps
Michel Desmons Pierre
Laferriere Craig Antony Joseph
Jan Poolman
Jean Paul Prieels
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909077.1A external-priority patent/GB9909077D0/en
Priority claimed from GBGB9909466.6A external-priority patent/GB9909466D0/en
Priority claimed from GBGB9916677.9A external-priority patent/GB9916677D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CO5210947A1 publication Critical patent/CO5210947A1/en

Links

Abstract

Un antígeno conjugado polisacárido que comprende un antígeno polisacárido derivado de una bacteria patógena conjugada con proteína D de Haemophilus influenzae o un fragmento de proteína D de ésta.Un polisacárido conjugado como se reivindica en la reivindicación 1, en el que el antígeno polisacárido se selecciona del grupo consistente en: polisacáridos Vi de Salmonella typhi, polisacáridos meningocóccicos, polisacáridos y polisacáridos modificados de meningococos del grupo B, polisacáridos de Staphylococcus aureus, polisacáridos de Streptococcus agalactae, polisacáridos de Streptococcus pneumoniae, polisacáridos de micobacterias, polisacáridos de Cryptococcus neoformans, lipopolisacáridos de Haemophilus influenzae no tipificables, polisacárido capsular de Haemophilus influenzae b, lipopolisacáridos de Moraxella catarrhalis, lipopolisacáridos de Shigella sonnei y lipopéptidofosfoglicanos (LPPG) de Trypanosoma cruzi.1Una composición inmunogénica que comprende polisacáridos capsulares conjugados de streptococcus pneumoiae, haemophilus influenzae b, meningococos C y meningococos Y, en la que la proteína vehículo para al menos uno de los polisacáridos es la proteína D de H. Influenzae.A polysaccharide conjugated antigen comprising a polysaccharide antigen derived from a pathogenic bacterium conjugated to Haemophilus influenzae D protein or a protein D fragment thereof. A conjugated polysaccharide as claimed in claim 1, wherein the polysaccharide antigen is selected from group consisting of: Vi polysaccharides of Salmonella typhi, meningococcal polysaccharides, polysaccharides and modified polysaccharides of group B, Staphylococcus aureus polysaccharides, Streptococcus agalactae polysaccharides, Streptococcharide polysaccharide polysaccharide polysaccharide polysaccharide, polysaccharide polysaccharide, polysaccharide polysaccharide, polysaccharide, polysaccharide polysaccharides Nontypable influenzae, Haemophilus influenzae b capsular polysaccharide, Moraxella catarrhalis lipopolysaccharides, Shigella sonnei lipopolysaccharides and lipopeptide phosphoglycans (LPPG) of Trypanosoma cruzi. 1 An immunogenic composition comprising conjugated capsular polysaccharides of streptococcus pneumoiae, haemophilus influenzae b, meningococci C and meningococci Y, in which the carrier protein for at least one of the polysaccharides is H. Influenzae protein D.

CO00027743A 1999-04-20 2000-04-14 IMMUNOGENIC COMPOSITIONS THAT INCLUDE A STREPTOCCUS PNEUMONIAE POLISACARIDE ANTIGEN CO5210947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909077.1A GB9909077D0 (en) 1999-04-20 1999-04-20 Novel compositions
GBGB9909466.6A GB9909466D0 (en) 1999-04-23 1999-04-23 Vaccines
GBGB9916677.9A GB9916677D0 (en) 1999-07-15 1999-07-15 Vaccine

Publications (1)

Publication Number Publication Date
CO5210947A1 true CO5210947A1 (en) 2002-10-30

Family

ID=40956460

Family Applications (3)

Application Number Title Priority Date Filing Date
CO00027739A CO5241277A1 (en) 1999-04-20 2000-04-14 VACCINE
CO00027740A CO5241278A1 (en) 1999-04-20 2000-04-14 VACCINE
CO00027743A CO5210947A1 (en) 1999-04-20 2000-04-14 IMMUNOGENIC COMPOSITIONS THAT INCLUDE A STREPTOCCUS PNEUMONIAE POLISACARIDE ANTIGEN

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CO00027739A CO5241277A1 (en) 1999-04-20 2000-04-14 VACCINE
CO00027740A CO5241278A1 (en) 1999-04-20 2000-04-14 VACCINE

Country Status (1)

Country Link
CO (3) CO5241277A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9714283B2 (en) 2014-10-28 2017-07-25 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9969793B2 (en) 2014-10-28 2018-05-15 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10683343B2 (en) 2014-10-28 2020-06-16 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US11339206B2 (en) 2014-10-28 2022-05-24 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US11780906B2 (en) 2014-10-28 2023-10-10 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11084870B2 (en) 2017-03-15 2021-08-10 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11897943B2 (en) 2017-03-15 2024-02-13 Adma Biomanufacturing, Llc Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Also Published As

Publication number Publication date
CO5241278A1 (en) 2003-01-31
CO5241277A1 (en) 2003-01-31

Similar Documents

Publication Publication Date Title
Chatterjee et al. Lipopolysaccharides of Vibrio cholerae: I. Physical and chemical characterization
AR052541A1 (en) GLICOCONJUGATED VACCINES CONTAINING PEPTIDOGLYCIN
CN1318446C (en) Transferrin receptor protein of Moraxella
BR9808772A (en) Composition of multivalent vaccine with mixed carrier
KR920003982A (en) Immunogenic Conjugates and Vaccine Compositions Containing the Same
HUP0002475A2 (en) Modified immunogenic pneumolysin compositions as vaccines
DE69315993D1 (en) CONJUGATES OF HEAT SHOCK PROTEINS AND OLIGO OR POLYSACCHARIDES
CA2366314A1 (en) Protein d from haemophilus influenzae as a carrier protein in combination vaccines
ATE135918T1 (en) IMPROVED VACCINE COMPOSITION
PT1235589E (en) Compositions comprising neisseria meningitidis antigens from serogroups b and c as well as a further antigen
MXPA05009351A (en) Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections.
CY1114041T1 (en) Injectable vaccines against multiple serogroups
TW200514569A (en) Vaccine composition
NO975366L (en) Vaccine composition containing polyribosylribitol phosphate and process for preparation thereof
ZA866564B (en) Conjugate vaccines against infections by gram-negative bacteria,process for their preparation and use thereof
CO5210947A1 (en) IMMUNOGENIC COMPOSITIONS THAT INCLUDE A STREPTOCCUS PNEUMONIAE POLISACARIDE ANTIGEN
Shelubsky Observations on the properties of a toxin produced by Microcystis: With 3 tables in the text
US6344200B1 (en) Lactoferrin receptor protein
AU3760795A (en) Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide
EP1035860A4 (en) Non-toxic immune stimulating enterotoxin compositions
Idris Characterization of Actinobacillus pleuropneumoniae hemolysin and its role in porcine Actinobacillus pleuropneumonia
RU2020112314A (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR APPLICATION IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN-CARRIER
RU2023120100A (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR APPLICATION IN POLYSACCHARIDE-PROTEIN-CARRIER IMMUNOGENIC CONJUGATES
PE20080774A1 (en) IMMUNOGENIC COMPOSITION INCLUDING PNAG OF STAPHYLACCOCES CONJUGATED WITH A CARRIER PROTEIN AND CAPSULAR POLYSACCHARIDE OR OLIGOSACCHARIDE OF S. AUREUS
RU2008131066A (en) PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN NMA0939

Legal Events

Date Code Title Description
FC Application refused